Hicham Jorio

As a biotech company, BIOTESSIA wants to play an active role in the solution put forward by the Moroccan Government, under the guidance of his majesty the King Mohamed VI, to improve Morocco’s HDI (Human Development Index) by boosting women’s financial independence and fighting gender inequality among other key indicators through numerous initiatives such as: Universal coverage in health insurance, investment in healthcare projects and other infrastructure projects, and setting a national committee tasked with the laying out of a new economic development model for the country. BIOTESSIA will focus on the IVD industry to strengthen Morocco’s independence regarding the world diagnostics market, as well as to work diligently towards an inclusive healthcare system by targeting the under-served and hard-to reach areas of the country. VISION To improve Morocco’s & Africa’s Human Development Index (HDI) and boost the well-being of their inhabitants all across the land. MISSION To import, manufacture, and distribute diagnostic tests that help detect most common diseases in Morocco & Africa, especially in the rural and secluded areas of the continent. OBJECTIVES Improve maternal and infant health Help detect emerging infectious diseases Provide testing for all major chronic and cardiovascular diseases

Mawitessia is a strategic alliance between Mawi DNA Technologies and Biotessia, two innovative biotech companies at the forefront of genomics and disease diagnostics. We harness the power of cutting-edge biotechnology to drive transformative change across Africa, advancing health sovereignty and sustainable development. Our core technology is focused on manufacturing high-quality, easy-to-transport collection kits for various sample types that require no cold chain logistics. By implementing efficient cell capture and release mechanisms, our innovative iSWAB kits maintain biosample integrity, enabling multiomics-based analysis and crafting a breakthrough in disease detection across the continent. Beyond being just a biotech company, Mawitessia is a beacon of hope and a testament to the boundless potential of African ingenuity. We are dedicated to enriching human health, enhancing agricultural productivity, and fostering resilience in our communities and environment. Join us as we shape the future of Africa, for Africans, by Africans. Follow us to stay updated on our transformative work.

SAVANA PARTNERS IS an international trading company based in Morocco . A strong partner for your international projects, SAVANA PARTNERS accompanies you by proposing a multitude of export, marketing, consulting, and trading services.

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The companys GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

Spire Ventures is a Silicon Valley–based venture capital firm investing in seed and Series A startups redefining the future of AI Biosciences, AI Software, and AI Semiconductors. We combine early-stage capital with deep operational enablement—building commercialization engines, offshoring technical teams to reduce burn, and developing strategic channel partnerships to accelerate global market entry. Our unique edge lies in hands-on venture development. Beyond financing, we empower founders with: Channel Partner Development — helping startups secure distribution, partnerships, and enterprise customers. MENA Expansion Gateway — bridging Silicon Valley innovation with emerging markets across the Middle East and North Africa. Offshore Sales & Engineering Support — building sustainable, capital-efficient teams to extend runway. Spire Ventures partners with visionary founders at the intersection of AI, deep tech, and global scalability, providing more than funding—we bring execution, expansion, and impact.

A great project schedule is critical to construction project profitability. 70% of projects are over budget, primarily due to poor schedule planning. CPM Scheduling is hard, and tools have not evolved in decades, as many construction professionals are still using a 100-year-old concept like a Gantt chart. Planera is a collaborative online whiteboard CPM software that is super simple yet very powerful. Using Planera, users create resource and cost-loaded schedules in hours instead of weeks. People with knowledge of the project can build sophisticated schedules themselves without the need for a scheduling expert or consultant, saving time and money, and reducing frustration.

Certified AI developers and growth hackers help businesses drive their growth, streamline decision-making, and get the most out of their data with custom solution.

As a biotech company, BIOTESSIA wants to play an active role in the solution put forward by the Moroccan Government, under the guidance of his majesty the King Mohamed VI, to improve Morocco’s HDI (Human Development Index) by boosting women’s financial independence and fighting gender inequality among other key indicators through numerous initiatives such as: Universal coverage in health insurance, investment in healthcare projects and other infrastructure projects, and setting a national committee tasked with the laying out of a new economic development model for the country. BIOTESSIA will focus on the IVD industry to strengthen Morocco’s independence regarding the world diagnostics market, as well as to work diligently towards an inclusive healthcare system by targeting the under-served and hard-to reach areas of the country. VISION To improve Morocco’s & Africa’s Human Development Index (HDI) and boost the well-being of their inhabitants all across the land. MISSION To import, manufacture, and distribute diagnostic tests that help detect most common diseases in Morocco & Africa, especially in the rural and secluded areas of the continent. OBJECTIVES Improve maternal and infant health Help detect emerging infectious diseases Provide testing for all major chronic and cardiovascular diseases

Mawitessia is a strategic alliance between Mawi DNA Technologies and Biotessia, two innovative biotech companies at the forefront of genomics and disease diagnostics. We harness the power of cutting-edge biotechnology to drive transformative change across Africa, advancing health sovereignty and sustainable development. Our core technology is focused on manufacturing high-quality, easy-to-transport collection kits for various sample types that require no cold chain logistics. By implementing efficient cell capture and release mechanisms, our innovative iSWAB kits maintain biosample integrity, enabling multiomics-based analysis and crafting a breakthrough in disease detection across the continent. Beyond being just a biotech company, Mawitessia is a beacon of hope and a testament to the boundless potential of African ingenuity. We are dedicated to enriching human health, enhancing agricultural productivity, and fostering resilience in our communities and environment. Join us as we shape the future of Africa, for Africans, by Africans. Follow us to stay updated on our transformative work.